Showing 521 - 540 results of 1,014 for search 'development reprogramming', query time: 0.19s Refine Results
  1. 521

    Revisiting TAM polarization: beyond M1- and M2-type TAM toward clinical precision in macrophage-targeted therapy by Qingqing Wang, Wenxue Ma

    Published 2025-09-01
    “…However, inconsistencies and mischaracterizations in the literature regarding TAM classification have led to confusion in the field, potentially impeding the development of effective macrophage-targeted immunotherapies. …”
    Get full text
    Article
  2. 522

    The role of tenascin-C in tumor microenvironments and its potential as a therapeutic target by Yaran Wang, Xiaohui Wen, Chao Su, Yanyi You, Ziqing Jiang, Qin Fan, Daoqi Zhu

    Published 2025-02-01
    “…The tumor microenvironment (TME) plays a pivotal role in cancer development and progression, and comprises various cellular and non-cellular components that interact with tumor cells. …”
    Get full text
    Article
  3. 523

    Research progress on cholesterol metabolism and tumor therapy by Zewen Chu, Lei Fang, Yanwei Xiang, Yue Ding

    Published 2025-04-01
    “…Cholesterol metabolism is involved in bile acid production and steroid hormone biosynthesis and is closely linked to the reprogramming of endogenous and exogenous cellular signals within the tumor microenvironment. …”
    Get full text
    Article
  4. 524

    Decidualization and Related Pregnancy Complications by Jing Tong, Shijian Lv, Jieqiong Yang, Hongwanyu Li, Weiya Li, Cong Zhang, Dandan Shi

    Published 2022-01-01
    “…Human decidualization involves some amount of signaling molecules and pathways as well as genetic reprogramming, which is driven by the postovulatory rise in progesterone levels and local cyclic adenosine monophosphate production. …”
    Get full text
    Article
  5. 525

    Non-parenchymal cells: key targets for modulating chronic liver diseases by Tongwang Yang, Zhiyun Gu, Juan Feng, Juanjuan Shan, Cheng Qian, Na Zhuang

    Published 2025-06-01
    “…These approaches provide valuable insights into halting CLD progression and advancing the development of innovative antifibrotic therapies.…”
    Get full text
    Article
  6. 526

    Melatonin: a natural guardian in cancer treatment by Yurou Cao, Hang Zhang, Xubin Chen, Conghui Li, Jingxin Chen

    Published 2025-07-01
    “…Mechanistically, melatonin inhibits tumor development through epigenetic regulation, metabolic reprogramming, immune micro-environment, and regulation of important signaling pathways (PI3K/AKT). …”
    Get full text
    Article
  7. 527

    Thymic Self-Antigen Expression for the Design of a Negative/Tolerogenic Self-Vaccine against Type 1 Diabetes by Aziz Alami Chentoufi, Vincent Geenen

    Published 2011-01-01
    “…Based on the close homology and cross-tolerance between insulin, the primary T1D autoantigen, and IGF-2, the dominant self-antigen of the insulin family, a novel type of vaccination, so-called “negative/tolerogenic self-vaccination”, is currently developed for prevention and cure of T1D. If this approach were found to be effective for reprogramming immunological tolerance in T1D, it could pave the way for the design of negative self-vaccines against autoimmune endocrine diseases, as well as other organ-specific autoimmune diseases.…”
    Get full text
    Article
  8. 528

    Amino acids in cancer: Understanding metabolic plasticity and divergence for better therapeutic approaches by Linda K. Do, Hyun Min Lee, Yun-Sok Ha, Chan-Hyeong Lee, Jiyeon Kim

    Published 2025-04-01
    “…Summary: Metabolic reprogramming is a hallmark of malignant transformation. …”
    Get full text
    Article
  9. 529

    Generation and characterization of two induced pluripotent stem cell lines (ICGi052-A and ICGi052-B) from a patient with frontotemporal dementia with parkinsonism-17 associated wit... by E. V. Grigor’eva, A. A. Malakhova, E. S. Yarkova, J. M. Minina, Y. V. Vyatkin, J. A. Nadtochy, E. A. Khabarova, J. A. Rzaev, S. P. Medvedev, S. M. Zakian

    Published 2024-11-01
    “…Two iPSC lines were characterised in detail. Reprogramming was performed by transfection with non-integrating episomal vectors expressing the OCT4, SOX2, KLF4, LIN28, L-MYC and mp53DD proteins. …”
    Get full text
    Article
  10. 530

    Anticancer Potential of Prebiotics: Targeting Estrogen Receptors and PI3K/AKT/mTOR in Breast Cancer by Hussein Sabit, Sama Abouelnour, Bassel M. Hassen, Salma Magdy, Ahmed Yasser, Al-Hassan Soliman Wadan, Shaimaa Abdel-Ghany, Faisal Radwan, Amany I. Alqosaibi, Hala Hafiz, Ohaad F. A. Awlya, Borros Arneth

    Published 2025-04-01
    “…Estrogen receptors (ERs) play a critical role in breast cancer (BC) development and progression, with ERα being oncogenic and ERβ exhibiting tumor-suppressive properties. …”
    Get full text
    Article
  11. 531
  12. 532

    The lactylation modification of proteins plays a critical role in tumor progression by Dehao Yi, Ke Zhou, Yinlong Pan, Huazhong Cai, Pan Huang, Pan Huang

    Published 2025-03-01
    “…Lactylation modifications have been shown to be a novel type of protein post-translational modifications (PTMs), providing a new perspective for understanding the interaction between cellular metabolic reprogramming and epigenetic regulation. Studies have shown that lactylation plays an important role in the occurrence, development, angiogenesis, invasion and metastasis of tumors. …”
    Get full text
    Article
  13. 533

    Epigenetics and Herbs: Potential Therapeutic Strategies for Osteoarthritis of the Knee by Zheng Y, Wang J, Wang L, Zheng Y, Qi W

    Published 2025-06-01
    “…Programmed cell death (PCD) of chondrocytes plays a central role in the development of knee osteoarthritis, and epigenetics provides new explanations for this complex biological process. …”
    Get full text
    Article
  14. 534
  15. 535

    Precision delivery of estrogen receptor antagonists using bioorthogonal chemistry-based intelligent nanocarriers to overcome cervical cancer drug resistance by Xue Yang, Yang Gu

    Published 2025-10-01
    “…Overcoming translational barriers and integrating multifunctional nanocarriers with immunomodulatory approaches, metabolic regulation, and artificial intelligence–based design may facilitate the development of advanced precision therapies for cervical cancer through the combined application of bioorthogonal chemistry and nanotechnology.…”
    Get full text
    Article
  16. 536

    Cytoplasmic injection of circular plasmids allows targeted expression in mammalian embryos by Khursheed Iqbal, Brigitte Barg-Kues, Sandra Broll, Jürgen Bode, Heiner Niemann, Wilfried A. Kues

    Published 2009-11-01
    “…This approach allows an experimental access to reprogramming events in early mammalian embryos.…”
    Get full text
    Article
  17. 537

    Tumor microenvironment-responsive nanoplatforms for enhanced cancer immunotherapy: Advances and synergistic strategies by Jie Wu, Xiangdong Xue, Haijing Qu

    Published 2025-12-01
    “…Furthermore, we elucidate synergistic mechanisms of TME-responsive nanosystems empowering immunotherapy: i) subcellular organelle-specific delivery, ii) TME remodeling, iii) immunometabolic reprogramming and iv) lymph node drainage regulation. …”
    Get full text
    Article
  18. 538

    Pathophysiological mechanisms of ARDS: a narrative review from molecular to organ-level perspectives by Kaihuan Zhou, Qianqian Qin, Junyu Lu

    Published 2025-02-01
    “…Main body By integrating classical theories with recent research advancements, we provide a comprehensive analysis of how inflammatory mediators, metabolic reprogramming, oxidative stress, and immune dysregulation synergistically drive ARDS onset and progression. …”
    Get full text
    Article
  19. 539

    System for Simultaneous Control of Multiple Unmanned Aerial Vehicles by Yehor Zheliazkov

    Published 2025-04-01
    “…Nowadays, airspace is a strategically important resource for both national security and economic development. The state is responsible for its efficient use and safety. …”
    Get full text
    Article
  20. 540

    A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease by Carmen Sevilla-Ortega, Alba Angelina, Leticia Martín-Cruz, Mario Pérez-Diego, Angel Maldonado, Begoña Lavín, Beatriz Marcos-Ramiro, Luis Pérez de Llano, Auba Gayá, Francisco X. Real, Laura Conejero, José Luis Subiza, Oscar Palomares

    Published 2025-08-01
    “…Abstract Allergic sensitization and viral infections are risk factors for asthma development and progression. Sublingual vaccination with MV130, a whole heat-inactivated polybacterial preparation, protects against viral infections, but its impact on allergic sensitization and asthma development remains unknown. …”
    Get full text
    Article